Home Your basket
• Balloon catheter dilatati...
   Price 10.50 €
• Reports to the General As...
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• Benefit of skull vibratio...
   Price 12.50 €
• Transoral surgical treatm...
   Price 8.50 €
• Anatomy of the external a...
   Price 14.00 €
• Treatment of children wit...
   Price 8.50 €
• The length of the piston ...
   Price 10.50 €
• Solitary myofibroma of th...
   Price 5.50 €
• The tensegrity concept ap...
   Price 10.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• Far-advanced otosclerosis...
   Price 10.50 €
• Results of fine needle as...
   Price 10.50 €
• Facial aesthetic lipostru...
   Price 10.50 €
• Influence of phonetic con...
   Price 10.50 €
• Multi-factorial analysis ...
   Price 10.50 €
• Interests of multimedia s...
   Price 10.50 €
• Cholesteatoma behind a no...
   Price 10.50 €
• Bilateral latero-pontine ...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Temporomandibular dysfunc...
   Price 10.50 €
• From barotrauma otitis to...
   Price 8.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Active bone conduction im...
   Price 12.00 €
• Vision preference in dyna...
   Price 10.50 €
• Recent advances in surger...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• A retrospective study of ...
   Price 10.50 €
• Otomycosis due to Scopula...
   Price 10.50 €
• The relevance of Choukrou...
   Price 10.50 €

Total Order 317.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE